User profiles for Julian A. Hiscox

Julian A. Hiscox

Chair in Infection and Global Health, University of Liverpool
Verified email at liverpool.ac.uk
Cited by 18909

[PDF][PDF] SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses

…, JL Griffin, RK Gupta, EM Harrison, JA Hiscox… - Cell, 2022 - cell.com
On 24 th November 2021, the sequence of a new SARS-CoV-2 viral isolate Omicron-B.1.1.529
was announced, containing far more mutations in Spike (S) than previously reported …

Neuropilin-1 is a host factor for SARS-CoV-2 infection

…, P Horvath, RB Sessions, A Helenius, JA Hiscox… - Science, 2020 - science.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), uses the viral spike (S) protein for host cell attachment …

Real-time, portable genome sequencing for Ebola surveillance

…, P Rachwal, D J. Turner, G Pollakis, JA Hiscox… - Nature, 2016 - nature.com
The Ebola virus disease epidemic in West Africa is the largest on record, responsible for over
28,599 cases and more than 11,299 deaths 1 . Genome sequencing in viral outbreaks is …

[PDF][PDF] Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B. 1.1. 7

…, M Unnikrishnan, AC Darby, JA Hiscox… - Cell reports, 2021 - cell.com
We report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70
in multiple independent lineages, often occurring after acquisition of receptor binding motif …

[HTML][HTML] ACE2: from vasopeptidase to SARS virus receptor

AJ Turner, JA Hiscox, NM Hooper - Trends in pharmacological sciences, 2004 - cell.com
The zinc metallopeptidase angiotensin-converting enzyme 2 (ACE2) is the only known
human homologue of the key regulator of blood pressure angiotensin-converting enzyme (ACE). …

[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …

…, T Fletcher, CA Green, JA Hiscox… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …

[HTML][HTML] Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the …

…, KJ Heesom, M Zambon, J Ellis, PA Lewis, JA Hiscox… - Genome medicine, 2020 - Springer
Background SARS-CoV-2 is a recently emerged respiratory pathogen that has significantly
impacted global human health. We wanted to rapidly characterise the transcriptomic, …

Tissue-specific immunopathology in fatal COVID-19

…, COC Bellamy, S Prost, C Smith, JA Hiscox… - American journal of …, 2021 - atsjournals.org
Rationale: In life-threatening coronavirus disease (COVID-19), corticosteroids reduce mortality,
suggesting that immune responses have a causal role in death. Whether this deleterious …

Virus genomes reveal factors that spread and sustained the Ebola epidemic

…, A Gnirke, A Goba, DS Grant, BL Haagmans, JA Hiscox… - Nature, 2017 - nature.com
The 2013–2016 West African epidemic caused by the Ebola virus was of unprecedented
magnitude, duration and impact. Here we reconstruct the dispersal, proliferation and decline of …

[HTML][HTML] Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa

MW Carroll, DA Matthews, JA Hiscox, MJ Elmore… - Nature, 2015 - nature.com
West Africa is currently witnessing the most extensive Ebola virus (EBOV) outbreak so far
recorded 1 , 2 , 3 . Until now, there have been 27,013 reported cases and 11,134 deaths. The …